Northbrook, IL, United States of America

Sushil G Devare

This inventor holds 21 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent, primarily in HIV Detection Technology. Top assignees: Abbott Laboratories Corporation, Other. Active years: 1992-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sushil G Devare. Retrieved from https://idiyas.com/inventor/sushil-g-devare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 1)

% Patents Active = 71.4

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 5.2

ph-index = 10

Forward Citations = 213(Granted Patents)

Company Filing History:

20 out of 4,190

Abbott Laboratories Corporation

patents

1 out of 834,601

Other

patents

Years Active: 1992-2014

Loading Chart...

Areas of Expertise:

Antigen Constructs

HIV Detection

Monoclonal Antibodies

Hepatitis C Assay

HIV-1 Detection

Recombinant Antigens

Mammalian Expression Systems

Diagnostic Tests

Fusion Proteins

Rapid Assays

Synthetic DNA

Antibody Differentiation

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8785596 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2014-07-22),

2. 7883845 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2011-02-08),

3. 7619061 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-17),

4. 7615614 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-10),

5. 7615613 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-10),

6. 6852491 - Amplification and detection reagents for HIV-1 (2005-02-08),

7. 6846905 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2005-01-25),

8. 6593083 - Hepatitis C assay utilizing recombinant antigens (2003-07-15),

9. 6538127 - Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria (2003-03-25),

10. 6172189 - Hepatitis C assay utilizing recombinant antigens (2001-01-09),

11. 6153377 - Synthetic DNA derived recombinant HIV antigens (2000-11-28),

12. 5922533 - Rapid assay for simultaneous detection and differentiation of antibodies (1999-07-13),

13. 5859193 - Synthetic DNA derived recombinant HIV antigens (1999-01-12),

14. 5854001 - Hepatitis C virus fusion proteins (1998-12-29),

15. 5753430 - Monoclonal antibodies to hepatitis C virus and method for using same (1998-05-19),

Title: The Innovative Journey of Sushil G Devare

Introduction: Sushil G Devare, a talented inventor hailing from Northbrook, IL (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Sushil G Devare holds several patents in various technological domains, showcasing his versatility and creativity in innovation.

Career Highlights: With a career spanning over two decades, Sushil G Devare has worked tirelessly to bring his innovative ideas to life. His dedication to pushing the boundaries of technology has led to the development of cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Sushil G Devare has collaborated with leading tech companies, research institutions, and universities to further his research and bring his inventions to the market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Sushil G Devare's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His contributions have not only advanced the field but have also inspired the next generation of inventors to dream big and push the boundaries of what is possible.

Profile summary based on public USPTO records.